The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Blood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data
Abstract
The National High Blood Pressure Education Program (NHBPEP) was launched 20 years ago based on data from population studies and clinical trials that showed high blood pressure (HBP) was a major unsolved—but soluble—mass public health problem. The present review summarizes recent data from US prospective population studies on blood pressure—systolic (SBP), diastolic (DBP)—and cardiovascular risk. The outcome variables include blood pressure-related risks, primarily incidence and mortality from coronary heart disease, stroke, other and all cardiovascular diseases (CVD); also cardiac abnormalites (roentgenographic, electrocardiographic, echocardiographic); also, all-cause mortality and life expectancy. Data accrued during the past 20 years confirm that SBP and DBP have continuous, graded, strong, independent, etiologically significant relationships to the outcome variables. These relationships are documented for young, middle-aged, and older men and for middle-aged and older women of varying socioeconomic backgrounds and ethnicity. Among persons aged 35 years or more, most have SBP/DBP above optimal (<120/<80 mm Hg); hence, they are at increased CVD risk, ie, the blood pressure problem involves most of the population, not only the substantial minority with clinical HBP. For middleaged and older persons, SBP relates even more strongly to risk than DBP; at every DBP level, higher SBP results in greater CVD risk and curtailment of life expectancy. A great potential exists for improved health and increased longevity through control of the blood pressure problem. Its realization requires a strategy combining populationwide and high-risk approaches, the former to prevent rise of blood pressure with age and to achieve primary prevention of HBP by nutritional-hygienic means; the latter to enhance detection, treatment, and control of HBP. The newly expanded goals of the NHBPEP, aimed at implementing this broader strategy for the solution of the blood pressure problem, merit active support from physicians and all health professionals. (Arch Intern Med. 1993;153:598-615)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Data from more than 347,000 middle-aged men (35 to 57 years) screened for the Multiple Risk Factor Intervention Trial (MRFIT) provide precise estimates of incremental risks with higher BP levels.There is a continuous, graded effect of BP on the multivariableadjusted relative risk for CHD mortality beginning at pressures well below 140 mm Hg. 59,60”
In the citing paper
“Thus, nearly two thirds of excess CHD deaths occurred in men with baseline SBP between 130 and 159 mm Hg, relatively ''mild'' levels of elevated BP.”
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 301–400 of 1,008
Non-pharmacological aspects of blood pressure management: what are the data?
Hedayati, S. S., Elsayed, E. F., & Reilly, R. F. (2011) · Kidney International · doi:10.1038/ki.2011.46 · Cited by 57
Blood pressure targets in adults with hypertension
Arguedas, J. A., Leiva, V., & Wright, J. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004349.pub3 · Cited by 59
“Therefore, elevated blood pressure has been identified as one of the major risk factors for adverse cardiovascular events (Kannel 1996; Rapsomaniki 2014; Stamler 1993; Stokes 1987).”
BackgroundHigher Heart Rate Predicts the Risk of Developing Hypertension in a Normotensive Screened Cohort
Inoue, T., Iseki, K., Iseki, C., Kinjo, K., Ohya, Y., & Takishita, S. (2007) · Circulation Journal · doi:10.1253/circj.71.1755 · Cited by 55
“For this purpose, participants without hypertension were assigned to 1 of 3 BP categories at baseline: (1) optimal; systolic BP <120mmHg and a diastolic BP of 80mmHg; (2) normal; systolic BP 120–129mmHg or diastolic BP 80–84mmHg; and (3) high normal; systolic BP 130–139mmHg or diastolic BP 85– 89mmHg.”
MethodIreland, D.-M., Clifton, P. M., & Keogh, J. B. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.02.006 · Cited by 54
Pedralli, M. L., Eibel, B., Waclawovsky, G., Schaun, M. I., Nisa-Castro-Neto, W., Umpierre, D., Pescatello, L. S., Tanaka, H., & Lehnen, A. M. (2018) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2018.09.009 · Cited by 57
Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus
Becker-Merok, A., & Nossent, J. C. (2009) · Lupus · doi:10.1177/0961203308099233 · Cited by 54
AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia
Quitterer, U., Lother, H., & AbdAlla, S. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2003.11.007 · Cited by 54
The fate of systemic blood pressure in patients after effectively stented coarctation
Eicken, A., Pensl, U., Sebening, W., Hager, A., Genz, T., Schreiber, C., Lang, D., Kaemmerer, H. M., Busch, R. M., & Hess, J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi748 · Cited by 54
The Long-term Prognostic Significance of Repeated Blood Pressure Measurements in the Elderly
Alli, C. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.11.1205 · Cited by 54
“Some authors(26-29) observed a similar prognostic significance for high DBP and SBP in the elderly, but the majority of prospective population studies suggest that DBP is a weaker indicator of cardiovascular risk than SBP, particularly with increasing age.(1,4,16,23-25,31,32,49-51) This behavior, unlike that observed…”
BackgroundFranco, V., Oparil, S., & Carretero, O. A. (2004) · Circulation · doi:10.1161/01.cir.0000132614.41493.b5 · Cited by 55
Antihypertensive Efficacy of Candesartan in Comparison to Losartan: The CLAIM Study
Bakris, G. L., Gradman, A. H., Reif, M. C., et al. (2001) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2001.00826.x · Cited by 53
“Epidemiologic data show that cardiovascular risk increases with every mm Hg of BP above 110/70 mm Hg.[8,9] In the cohort of men screened for the Multiple Risk Factor Intervention Trial (MRFIT),[ 9 ] SBP increases of 20 mm Hg and 40 mm Hg increased the 11.6-year risk of coronary heart disease deaths by 156% and 244%, r…”
BackgroundInfluentialAngiotensin II, nitric oxide, and end-organ damage in hypertension
Bataineh, A., & Raij, L. R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06806.x · Cited by 53
Visit-to-Visit Blood Pressure Variability, Neuropathology, and Cognitive Decline
Ma, Y., Blacker, D., Viswanathan, A., van Veluw, S. J., Bos, D., Vernooij, M. W., Hyman, B. T., Tzourio, C., Das, S., & Albert Hofman, D. (2021) · Neurology · doi:10.1212/wnl.0000000000012065 · Cited by 56
“We primarily assessed visit-to-visit variability in systolic BP (SBP) because of its stronger association with adverse health outcomes.(18) We also repeated the analyses for diastolic BP (DBP).”
BackgroundBlood Pressure and Glaucomatous Progression in a Large Clinical Population
Jammal, A. A., Berchuck, S. I., Mariottoni, E. B., Tanna, A. P., Costa, V. P., & Medeiros, F. A. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2021.08.021 · Cited by 55
Association of Brief Health Literacy Screening and Blood Pressure in Primary Care
Willens, D. E., Kripalani, S. B., Schildcrout, J. S., Cawthon, C. R., Wallston, K., Mion, L. C., Davis, C. M., Danciu, I., Rothman, R. L., & Roumie, C. L. (2013) · Journal of Health Communication · doi:10.1080/10810730.2013.825663 · Cited by 55
Delisle, H. F. (2002) · World Health Organization eBooks · Cited by 53
Uchiyama, S., Shibata, Y., Hirabayashi, T., Mihara, B., Hamashige, N., Kitagawa, K., Goto, S., Origasa, H., Shimada, K., Kobayashi, H., et al. (2010) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2009.04.004 · Cited by 51
Epidemiology and prevention of hypertension in Japanese: how could Japan get longevity?
Miura, K. (2011) · The EPMA Journal · doi:10.1007/s13167-011-0069-y · Cited by 52
“Hypertension has been acknowledged as one of the greatest and established risk factors for cardiovascular diseases (CVD) (heart diseases and stroke) [1–4].”
BackgroundEffects of Prehypertension on Arterial Stiffness and Wave Reflections
Gedikli, Ö., Kırış, A., Öztürk, S., et al. (2010) · Clinical and Experimental Hypertension · doi:10.3109/10641960902993103 · Cited by 51
ASH position paper: Dietary approaches to lower blood pressure
Appel, L. J. (2010) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2010.03.004 · Cited by 52
Smith, D. H. G. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80056-x · Cited by 52
Hypertension and Mild Cognitive Impairment
Sierra, C., Doménech, M., Camafort, M., & Coca, A. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0315-2 · Cited by 55
“Although a continuous relationship between both systolic and diastolic BP and the occurrence of stroke has been well established, there is epidemiological evidence from the MRFIT study (Multiple Risk Factor Intervention Trial) that the systolic component of BP may exert a strong deleterious effect on cerebrovascular d…”
Law, M. R., Wald, N., & Morris, J. K. (2004) · Journal of Medical Screening · doi:10.1177/096914130301100102 · Cited by 50
Parmar, P. G. K., Taal, H. R., Timpson, N. J., Thiering, E., Lehtimäki, T. J., Marinelli, M., Lind, P. A., Howe, L. D., Verwoert, G. C., Aalto, V., et al. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.115.001190 · Cited by 52
Modificação do padrão respiratório melhora o controle cardiovascular na hipertensão essencial
Pinheiro, C. H. D. J., Medeiros, R. A. R., Pinheiro, D. G. M., & Marinho, M. D. J. F. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007000600005 · Cited by 51
Pharmacoeconomic Considerations in the Management of Hypertension
Pardell, H., Tresserras, R., Armario, P., & ndez, R. H. (2000) · Drugs · doi:10.2165/00003495-200059002-00002 · Cited by 50
Graciani, A., Zuluaga, M. C., Banegas, J. R., León-Muñoz, L. M., de la Cruz, J. J., & Rodríguez‐Artalejo, F. (2008) · Medicina Clínica · doi:10.1157/13124098 · Cited by 49
Blood Pressure and Cardiovascular Disease
Furberg, C. D., Psaty, B. M., & Soliman, E. Z. (2009) · Wiley eBooks · doi:10.1002/9781444309768.ch13 · Cited by 48
AlGhatrif, M., Kuo, Y., Snih, S. A., Raji, M. A., Ray, L. A., & Markides, K. S. (2010) · Annals of Epidemiology · doi:10.1016/j.annepidem.2010.06.002 · Cited by 48
“) affecting more than 72 million Americans (1–3), it is a major modifiable risk factor for cardiovascular disease (4,5).”
BackgroundRuppar, T. M. (2010) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3181d5f9c5 · Cited by 49
The veterans' study to improve the control of hypertension (V-STITCH): design and methodology
Bosworth, H. B., Olsen, M. K., Goldstein, M. K., Orr, M., Dudley, T. K., McCant, F., Gentry, P., & Oddone, E. Ž. (2005) · Contemporary Clinical Trials · doi:10.1016/j.cct.2004.12.006 · Cited by 48
“Hypertension is the major modifiable risk factor for stroke and one of the major risk factors for coronary heart disease, congestive heart failure, and renal disease [2–4].”
BackgroundMethodAssessing coronary heart disease risk with traditional and novel risk factors
Wilson, P. W. F. (2004) · Clinical Cardiology · doi:10.1002/clc.4960271504 · Cited by 48
DiCarlo, S. E., Zheng, H., Collins, H. L., Rodenbaugh, D. W., & Patel, K. P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03400-5 · Cited by 48
Cardiovascular and Metabolic Risk Factors: How Can We Improve Outcomes in the High-Risk Patient?
Grundy, S. M. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.06.005 · Cited by 48
Whelton, P. K., Beevers, D. G., & Sonkodi, S. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001738 · Cited by 47
Achieving Blood Pressure Goals: Why Aren't We?
Cushman, W. C., & Basile, J. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.05789.x · Cited by 46
Management of hypertension in women
Engberding, N., & WENGER, N. K. (2011) · Hypertension Research · doi:10.1038/hr.2011.210 · Cited by 47
Wills, A. K., Hardy, R., Black, S., & Kuh, D. J. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328335de7b · Cited by 45
Prevention and treatment of stroke in patients with hypertension
Mancia, G. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90065-3 · Cited by 45
Erlinger, T. P., Vollmer, W. M., Svetkey, L. P., & Appel, L. J. (2003) · Preventive Medicine · doi:10.1016/s0091-7435(03)00140-3 · Cited by 46
Sutton‐Tyrrell, K., Alcorn, H. G., Herzog, H. C., et al. (1995) · Stroke · doi:10.1161/01.str.26.8.1319 · Cited by 46
The American Heart Association Dietary Guidelines for 2000: A Summary Report
Lauber, R. P., & Sheard, N. F. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2001.tb07021.x · Cited by 44
Mourad, J. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4073 · Cited by 45
“This relationship, which has been demonstrated in a range of patient populations and age groups, is strong and continuous (Kannel et al 1971; MacMahon et al 1990; Stamler et al 1993; Adler et al 2000; Staessen et al 2000; Padwal et al 2001; Lewington et al 2002).”
InfluentialLópez, L., Cook, E. F., Horng, M. S., & Hicks, L. S. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.348 · Cited by 47
TENS attenuates response to colon distension in paraplegic and quadriplegic rats
Collins, H. L., & DiCarlo, S. E. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00253.2002 · Cited by 45
“A continuous, strong, graded, independent and etiologically significant relationship between elevated blood pressure and cardiovascular and cerebrovascular risk has been described (35).”
BackgroundLotfaliany, M., Akbarpour, S., Mozaffary, A., Boloukat, R. R., Azizi, F., & Hadaegh, F. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000540 · Cited by 44
“H ypertension is known to be a strong risk factor for cardiovascular disease (CVD) [1,2], which is a leading cause of disability and death globally [3,4].”
BackgroundCollier, S. R. (2008) · Gender Medicine · doi:10.1016/j.genm.2008.06.002 · Cited by 44
Alomari, M. A., Keewan, E. F., Qhatan, R. A., Amer, A., Khabour, O. F., Maayah, M. F., & Hurtig‐Wennlöf, A. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.531848 · Cited by 43
“Hypertension has reached an epidemic level (1) and is a well-established risk factor as the relationship with cardiovascular-related morbidity and mortality is direct, strong, continuous, graded, consistent, and independent (2).”
BackgroundPitsavos, C. S., Milias, G. A., Panagiotakos, D. B., Xenaki, D., Panagopoulos, G., & Stefanadis, C. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-206 · Cited by 43
Hypertension: a cross-sectional study of the role of multimorbidity in blood pressure control
Sarkar, C. N., Dodhia, H., Crompton, J., Schofield, P., White, P. T., Millett, C. J., & Ashworth, M. J. (2015) · BMC Family Practice · doi:10.1186/s12875-015-0313-y · Cited by 42
Tat, J., Au, J. S., Keir, P. J., et al. (2015) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12270 · Cited by 42
“Cardiovascular events during systole, such as elevated systolic blood pressure (Stamler et al., 1993), are implicated in the development of cardiovascular risk, and therefore, the timing of retrograde motion may help to explain its clinical significance.”
BackgroundMedication Beliefs and Antihypertensive Adherence Among Older Adults: A Pilot Study
Ruppar, T. M., Dobbels, F., & Geest, S. D. (2012) · Geriatric Nursing · doi:10.1016/j.gerinurse.2012.01.006 · Cited by 42
Kirkham, A. A., Lloyd, M. G., Claydon, V. E., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0049 · Cited by 42
American‐Style Football and Cardiovascular Health
Kim, J. H., ZAFONTE, R. D., Pascuale‐Leon, A., Nadler, L. M., Weisskopf, M. G., Speizer, F. E., Taylor, H. A., & Baggish, A. L. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008620 · Cited by 42
“Hypertension during young adulthood, the time period that coincides with competitive ASF participation, is a wellestablished independent risk factor for later life cardiovascular disease morbidity and mortality.(9,10,50) In the prospective Harvard Alumni Health Study of 18 881 male”
BackgroundThe role of blood pressure in risk of ischemic and hemorrhagic stroke in type 1 diabetes
the FinnDiane Study Group, Hägg-Holmberg, S., Dahlström, E. H., Forsblom, C. M., Harjutsalo, V., Liebkind, R., Putaala, J., Tatlisumak, T., Groop, P., & Thorn, L. M. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0891-4 · Cited by 45
“of stroke As in the general population [19, 20], SBP seems to be a very strong risk factor for stroke also in type 1 diabetes.”
BackgroundChen, L., Peeters, A., Magliano, D. J., Shaw, J. E., Welborn, T. A., Wolfe, R. S., Zimmet, P., & Tonkin, A. M. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32816f7739 · Cited by 41
High prevalence of cardiovascular risk factors among policemen in Puducherry, South India
Ramakrishnan, J., Majgi, S. M., Premarajan, K. C., Lakshminarayanan, S., Thangaraj, S., & Chinnakali, P. (2013) · Journal of Cardiovascular Disease Research · doi:10.1016/j.jcdr.2013.05.002 · Cited by 40
Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase
Liu, C., Kellems, R. E., & Xia, Y. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx027 · Cited by 40
Epstein, M. (2001) · Heart Disease · doi:10.1097/00132580-200111000-00008 · Cited by 40
Improving blood pressure control by tailored feedback to patients and clinicians
Bosworth, H. B., Olsen, M. K., & Oddone, E. Ž. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.01.039 · Cited by 40
Metabolic Syndrome and Early Death
Franks, P. W., & Olsson, T. (2006) · Hypertension · doi:10.1161/01.hyp.0000251934.55488.ae · Cited by 40
Lee, J., Sohn, J., Park, J., Yang, S.-M., Lee, S., & Kim, H. C. (2018) · BioMedical Engineering OnLine · doi:10.1186/s12938-018-0510-8 · Cited by 40
Fine, A., Fontaine, B., & Ma, M. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v881311 · Cited by 39
The Future of Hypertension Therapy: Sense, Antisense, or Nonsense?
Pachori, A. S., Huentelman, M. J., Francis, S., Gelband, C. H., Katovich, M. J., & Raizada, M. K. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.357 · Cited by 39
“(4) Is the expression of the AT1R-ASof any consequence in the normotensive rat? Our studies have established that although AT1R-AS/ACE-ASis equally expressed in both normotensive rats and SHR, the expression is of little consequence on basal BP in normal rats.”
BackgroundBlood Pressure Control and Benefits of Antihypertensive Therapy
Ruilope, L. M., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.095760 · Cited by 37
Zm, L., Ho, S. C., Chen, Y.-M., Tomlinson, B., To, K., To, K., & Woo, J. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.24 · Cited by 39
Muntner, P., Levitan, E. B., Reynolds, K., Mann, D. M., Tonelli, M. A., Oparil, S., & Shimbo, D. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00581.x · Cited by 38
“The prognostic value of blood pressure (BP) is based on the average of multiple measurements taken during a single or multiple visits.(1,2) The American Heart Association recommends that BP be measured 2 times during all outpatient encounters and averaged to represent a patient’s BP.”
BackgroundAngiotensin‐converting enzyme 2 as a novel target for gene therapy for hypertension
Katovich, M. J., Grobe, J. L., Huentelman, M. J., & Raizada, M. K. (2005) · Experimental Physiology · doi:10.1113/expphysiol.2004.028522 · Cited by 38
“This condition of a sustained elevation in BP contributes to serious health complications such as myocardial ischaemia and infarction, renal failure, stroke and retinal damage (Stamler et al. 1993; Whelton, 1994).”
BackgroundThe problem of uncontrolled hypertension
Lindholm, L. H. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001433 · Cited by 38
Persson, M., Carlberg, B., Tavelin, B., & Lindholm, L. H. (2004) · Journal of Hypertension · doi:10.1097/00004872-200401000-00014 · Cited by 37
Seong, E., Bose, S., Han, S.-Y., Song, E., Lee, M.-J., Nam, Y., & Kim, H. (2021) · The EPMA Journal · doi:10.1007/s13167-021-00243-4 · Cited by 37
The nephrologist in the HAART era
Izzedine, H., & Deray, G. (2007) · AIDS · doi:10.1097/qad.0b013e328011ec40 · Cited by 37
“a continuous relationship between elevations in blood pressure, cardiovascular disease and death [111].”
BackgroundSarafidis, P. A., Lasaridis, A. N., Gousopoulos, S., et al. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001724 · Cited by 37
Duncan, G. E., Anton, S. D., Newton, R. L., & Perri, M. G. (2003) · Preventive Medicine · doi:10.1016/s0091-7435(03)00017-3 · Cited by 38
Zreikat, H. H., Harpe, S. E., Slattum, P. W., Mays, D. P., Essah, P. A., & Cheang, K. I. (2013) · Metabolism · doi:10.1016/j.metabol.2013.11.006 · Cited by 36
“In addition, elevated systolic blood pressure is common among older individuals, which is our population under study [26,27].”
BackgroundChronic obstructive pulmonary disease is independently associated with hypertension in men
Kim, S. H., Park, J.-H., Lee, J., Heo, E. Y., Kim, D. K., & Chung, H. S. (2017) · Medicine · doi:10.1097/md.0000000000006826 · Cited by 37
Assessing diets to improve world health: nutritional research on disease causation in populations
Stamler, J. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.1.146s · Cited by 36
Self-citationGreenlund, K. J., Daviglus, M. L., & Croft, J. B. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832926fb · Cited by 34
Karmali, K. N., Ning, H., Goff, D. C., & Lloyd‐Jones, D. M. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002126 · Cited by 35
Emotional and instrumental support during childhood and biological dysregulation in mid-life
Slopen, N., Chen, Y., Priest, N., Albert, M., & Williams, D. R. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.12.003 · Cited by 35
“Furthermore, the selected indicators/systems have been shown to be associated with chronic disease (Cooney et al., 2009, 2010; Danesh et al., 1998; de Koning et al., 2007; Muntner et al., 2005; Prospective Studies Collaboration, 2007; Stamler et al., 1993).”
Elevated Blood Pressure in the Emergency Department
Oras, P., Häbel, H., Skoglund, P. H., & Svensson, P. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.14002 · Cited by 35
Soppa, V., Schins, R. P. F., Hennig, F., Nieuwenhuijsen, M. J., Hellack, B., Quaß, U., Kaminski, H., Sasse, B., Shinnawi, S., Kuhlbusch, T. A. J., et al. (2017) · Environmental Research · doi:10.1016/j.envres.2017.06.006 · Cited by 36
Phillips, R. A., Kloner, R. A., Grimm, R. H., & Weinberger, M. H. (2003) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2003.01416.x · Cited by 36
Black, H. R., & Yi, J.-Y. (1996) · Hypertension · doi:10.1161/01.hyp.28.5.719 · Cited by 34
Schillaci, G., Pirro, M., & Mannarino, E. (2009) · Circulation · doi:10.1161/circulationaha.108.827931 · Cited by 34
Kim, S., Park, G.-H., Yang, J. H., Chun, S. H., Yoon, H., & Park, M.-S. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.9 · Cited by 32
Rineer, J. R., Truxillo, D. M., Bodner, T., Hammer, L. B., & Kraner, M. (2017) · European Journal of Work and Organizational Psychology · doi:10.1080/1359432x.2016.1277207 · Cited by 33
Pharmacoeconomic Burden of Undertreating Hypertension
Esposti, L. D., & Valpiani, G. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422140-00002 · Cited by 33
Absence of Age-Related Increase in Systolic Blood Pressure in Ambulatory Patients with HIV Infection
MATTANA, J., Siegal, F. P., Sankaran, R. T., & Singhal, P. C. (1999) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199904000-00004 · Cited by 34
Blood pressure variability, dementia, and role of antihypertensive medications in older adults
Mahinrad, S., Bennett, D. A., Sorond, F. A., & Gorelick, P. B. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12935 · Cited by 32
The Effect of Age on Risk Factors for Ischemic Heart Disease
TATE, R. B., Manfreda, J., & Cuddy, T. E. (1998) · Annals of Epidemiology · doi:10.1016/s1047-2797(98)00011-8 · Cited by 32
Trends in hypertension care in eastern and south-western Finland during 1982–2002
Kastarinen, M. J., Antikaínen, R., Laatikainen, T. K., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222751.90443.0a · Cited by 32
Sager, P. T., Heilbraun, J., Turner, J. R., Gintant, G. A., Geiger, M. J., Kowey, P. R., Mansoor, G. A., Mendzelevski, B., Michelson, E. L., Stockbridge, N., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.01.002 · Cited by 32
“There is powerful epidemiologic evidence showing that as BP increases in a population, the risk of cardiovascular (CV) events increases.(10,11) In addition, multiple placebo-controlled clinical trials over the past 4”
BackgroundBüsst, C., Scurrah, K. J., Ellis, J. A., & Harrap, S. B. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.089128 · Cited by 31
Motta, V., Favero, C., Dioni, L., Iodice, S., Battaglia, C., Angelici, L., Vigna, L., Pesatori, A. C., & Bollati, V. (2016) · Environmental Research · doi:10.1016/j.envres.2016.01.010 · Cited by 33
Obesity, Visceral Fat, and Hypertension-Related Complications
Haberka, M., Stolarz‐Skrzypek, K., Biedroń, M., Szóstak-Janiak, K., Partyka, M., Olszanecka‐Glinianowicz, M., & Gąsior, Z. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0062 · Cited by 31
Kirkham, A. A., Beka, V., & Prado, C. M. M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.06.029 · Cited by 31
Hypertension and the Role of Dietary Fiber
Nepali, P., Suresh, S., Pikale, G., Jhaveri, S., Avanthika, C., Bansal, M., Islam, R., & Chanpura, A. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101203 · Cited by 38
Perioperative control of hypertension: When will it adversely affect perioperative outcome?
Sear, J. W. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0090-2 · Cited by 31
Prehypertension and endothelial progenitor cell function
MacEneaney, O. J., DeSouza, C. A., Weil, B. R., Kushner, E. J., Guilder, G. P. V., Mestek, M. L., Greiner, J. J., & Stauffer, B. L. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.31 · Cited by 30
“increased risk of myocardial infarction and ischemic stroke, are attributable to elevations in systolic BP (22;23).”
Background
Metadata
- Authors
- Stamler, J.
- Corresponding author
- Stamler, Jeremiah
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 1993-03-08
- Volume
- 153
- Issue
- 5
- Pages
- 598
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2608915729
- Cited by
- 1,015
- References
- 0
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 17 · 2023: 24 · 2022: 22 · 2021: 27 · 2020: 26 · 2019: 31 · 2018: 39 · 2017: 24 · 2016: 21 · 2015: 36 · 2014: 30 · 2013: 31 · 2012: 43
- FWCI
- 12.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- blood pressure, systolic blood pressure, diastolic blood pressure, cardiovascular risk, hypertension, coronary artery disease, stroke, cardiovascular mortality, life expectancy, primary prevention, hypertension control, National High Blood Pressure Education Program, population-based prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review